Blue Owl Capital Holdings LP Keros Therapeutics, Inc. Transaction History

Blue Owl Capital Holdings LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$10.15 - $16.1 $237,510 - $376,740	23,400 Added 9.64%	266,033 $2.71 Million
Q4 2024 Feb 14, 2025	BUY	$15.64 - $70.0 $1.88 Million - $8.4 Million	120,000 Added 97.85%	242,633 $3.84 Million
Q3 2024 Nov 14, 2024	SELL	$41.68 - $58.07 $1.46 Million - $2.03 Million	-35,000 Reduced 22.2%	122,633 $7.12 Million
Q2 2024 Aug 15, 2024	SELL	$44.58 - $66.89 $668,700 - $1 Million	-15,000 Reduced 8.69%	157,633 $7.2 Million
Q1 2024 May 15, 2024	SELL	$41.26 - $70.48 $7.43 Million - $12.7 Million	-180,000 Reduced 51.04%	172,633 $11.4 Million

Q4 2023 Feb 14, 2024	BUY	$27.12 - $41.05 $9.56 Million - $14.5 Million	352,633 New	352,633 $14 Million

169

35.4M

574K

325K

Ticker KROS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,757,000
Market Cap $445M
Description
Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...

Get notified when there are updates to the investment portfolio of Blue Owl Capital Holdings LP, based on Form 13F filings with the SEC.

Stay updated on Blue Owl Capital Holdings LP with notifications on news.